First Trust NYSE Arca Biotechnology Index FundFBT
Type
ETF
Peer group
US equity: Healthcare
Net assets
$2.3B
Expense ratio
0.55%
1-year return
+55.2%
3 years, a year
+20.3%
5 years, a year
+9.1%
12-month yield
0.00%
Holdings
32
What it aims to do.
The First Trust NYSE Arca Biotechnology Index Fund (the Fund ) seeks investment results that correspond generally to the price and yield (before the Funds fees and expenses) of an equity index called the NYSE Arca Biotechnology Index (the Index ).
Top 10 holdings.
| Holding | % of fund |
|---|---|
| MRNA Moderna Inc | 5.26% |
| UTHR United Therapeutics Corporation | 4.36% |
| JOBY Alkermes PLC | 4.23% |
| GILD Gilead Sciences Inc. | 4.09% |
| AXSM Axsome Therapeutics Inc. | 3.89% |
| AMGN Amgen Inc. | 3.83% |
| CORT Corcept Therapeutics Inc. | 3.82% |
| KRYS Krystal Biotech Inc | 3.51% |
| BIIB Biogen Inc | 3.47% |
| EXEL Exelixis, Inc. | 3.46% |
More on FBT.
- FBT overview
- FBT holdings
- FBT risk
- FBT costs
- FBT money in and out
- FBT share classes
- Compare FBT with other funds
Returns after fees, from the fund's SEC filings up to Aug 2026. Past returns are not a promise. Not financial advice.